Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study.
Michel M, Saïr M, Rivière E, Moulis G, Comont T, Costedoat-Chalumeau N, Pouchelon C, Boutboul D, Benyamine A, Bert A, Jeandel PY, Hamrouni S, Belfeki N, Lobbes H, Dossier A, Gobert D, Mahevas M, Godeau B, Gallien Y, Ebbo M. Michel M, et al. Among authors: moulis g. Am J Hematol. 2024 Aug;99(8):1616-1619. doi: 10.1002/ajh.27361. Epub 2024 May 14. Am J Hematol. 2024. PMID: 38742870 No abstract available.
Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.
Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, Roy-Peaud F, Jeandel PY, Crickx E, Dossier A, Gobert D, Hadjadj J, Puyade M, Languille L, Rasmussen C, Terrier B, Ebbo M, Bonnotte B, Audia S, Galicier L, Michel M, Mahevas M, Viallard JF, Godeau B; CERECAI (Centre de Référence des Cytopénies Auto-Immunes de L'adulte). Sorin B, et al. Among authors: moulis g. Am J Hematol. 2023 Sep;98(9):E259-E262. doi: 10.1002/ajh.27016. Epub 2023 Jul 6. Am J Hematol. 2023. PMID: 37410544 Free article. No abstract available.
Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.
Guillet S, Crickx E, Azzaoui I, Chappert P, Boutin E, Viallard JF, Rivière E, Gobert D, Galicier L, Malphettes M, Cheze S, Lefrere F, Audia S, Bonnotte B, Lambotte O, Noel N, Fain O, Moulis G, Hamidou M, Gerfaud-Valentin M, Marolleau JP, Terriou L, Martis N, Morin AS, Perlat A, Le Gallou T, Roy-Peaud F, Robbins A, Lega JC, Puyade M, Comont T, Limal N, Languille L, Zarrour A, Luka M, Menager M, Belmondo T, Hue S, Canoui-Poitrine F, Michel M, Godeau B, Mahévas M. Guillet S, et al. Among authors: moulis g. Blood. 2023 Jun 8;141(23):2867-2877. doi: 10.1182/blood.2022018665. Blood. 2023. PMID: 36893453 Free article.
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience.
Crickx E, Ebbo M, Rivière E, Souchaud-Debouverie O, Terriou L, Audia S, Ruivard M, Asli B, Marolleau JP, Méaux-Ruault N, Gerfaud-Valentin M, Audeguy P, Hamidou M, Corm S, Delbrel X, Fontan J, Lebon D, Mausservey C, Moulis G, Limal N, Michel M, Godeau B, Mahévas M. Crickx E, et al. Among authors: moulis g. Br J Haematol. 2023 Aug;202(4):883-889. doi: 10.1111/bjh.18893. Epub 2023 May 29. Br J Haematol. 2023. PMID: 37247631
Adolescents and young adults with newly diagnosed primary immune thrombocytopenia.
Schifferli A, Moulis G, Godeau B, Leblanc T, Aladjidi N, Michel M, Leverger G, Elalfy M, Grainger J, Chitlur M, Heiri A, Holzhauer S, Le Gavrian G, Imbach P, Kühne T. Schifferli A, et al. Among authors: moulis g. Haematologica. 2023 Oct 1;108(10):2783-2793. doi: 10.3324/haematol.2022.282524. Haematologica. 2023. PMID: 37051753 Free PMC article.
Relapsing polychondritis: clinical updates and new differential diagnoses.
Mertz P, Costedoat-Chalumeau N, Ferrada MA, Moulis G, Mekinian A, Grayson PC, Arnaud L. Mertz P, et al. Among authors: moulis g. Nat Rev Rheumatol. 2024 Jun;20(6):347-360. doi: 10.1038/s41584-024-01113-9. Epub 2024 May 2. Nat Rev Rheumatol. 2024. PMID: 38698240 Review.
Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia.
Delcros Q, Taillé C, Vallée A, Brun AL, Chenivesse C, Couture P, Daboussi S, Guilleminault L, Juster F, Kahn JE, Lefèvre G, Liozon E, Magnan A, Meireles S, Moulis G, Puech C, Tcherakian C, Traclet J, Uzunhan Y, Cottin V, Groh M; CEREO, OrphaLung, and CRISALIS Networks. Delcros Q, et al. Among authors: moulis g. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1317-1319.e1. doi: 10.1016/j.jaip.2022.12.022. Epub 2022 Dec 26. J Allergy Clin Immunol Pract. 2023. PMID: 36581069 No abstract available.
Long term follow-up of the STOPAGO study.
Cottu A, Guillet S, Viallard JF, Riviere E, Cheze S, Gobert D, Neel A, Graveleau J, Marolleau JP, Lefrere F, Moulis G, Lega JC, Moignet A, Robbins A, Crickx E, Boutin E, Noel N, Malphettes M, Galicier L, Audia S, Bonnotte B, Lambotte O, Fain O, Gerfaud-Valentin M, Terriou L, Martis N, Morin AS, Perlat A, Le Gallou T, Roy-Peaud F, Puyade M, Comont T, Limal N MD, Languille L, Michel M, Godeau B, Mahevas M. Cottu A, et al. Among authors: moulis g. Blood. 2024 Oct 30:blood.2024025707. doi: 10.1182/blood.2024025707. Online ahead of print. Blood. 2024. PMID: 39476101
178 results